Skip to main content
. 2012 May 16;2012(5):CD008344. doi: 10.1002/14651858.CD008344.pub2
Methods Randomised trial comparing supplements (branched‐chain amino acids) to no supplements in outpatients with cirrhosis. Geographical location Barcelona, Spain. Paper published 1988.
Participants Inclusion criteria: Cirrhosis (almost all of the patients were Childs B or C). Exclusion criteria: None cited. 49 patients (31 men/18 women , mean age 54).
Interventions Intervention group received nutritional supplement (branched‐chain amino acid‐enriched amino acid supplement [65 gm/d in 300 cc water {2224 kcal, 19.6 gm amino acids with 40% as branched chain‐amino acids}]; Controls did not receive supplement. All participants received 80‐90‐gm protein diet, standard treatment for complications. Duration therapy six months.
Outcomes Mortality, appearance hepatic encephalopathy, bilirubin, triceps skinfold thickness, midarm muscle circumference.
Category of study Supplements/Medical.
Sample size calculation Not reported if done.
Full paper or abstract only Full report.
Notes Number of episodes of hepatic encephalopathy were total; for purposes of meta‐analysis, assumed one per patient. Article in Spanish. Unable to find any contact address or e‐mail for Dr Humbert, so no request sent for further information.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Table of random numbers.
Allocation concealment (selection bias) Unclear risk No details.
Blinding (performance bias and detection bias) All outcomes High risk Not blinded.
Incomplete outcome data (attrition bias) All outcomes Low risk Two and four dropouts in treatment and control groups accounted for.
Selective reporting (reporting bias) Low risk Mortality and morbidity outcomes reported.
Other bias Unclear risk Funder not reported.
Intent to treat analysis Low risk Although dropouts noted, denominators in paper were all randomised patients.
Baseline imbalance? Low risk No differences identified.
Early stopping? Unclear risk No sample size calculation and unknown why stopped.